Just to touch on the Atomo RAT test, JK repeatedly stressed that it was an 'accessory' that they are developing and not an entire test. So regulatory approvals won't be as lengthy. So I'm assuming it is an accessory to their already developed devices. This would be the product JK references when he talks of the wider respiratory diseases market. I.e a test to differentiate flu vs covid. JK saying Atomo isn't involved in Lumos Covidx also gives me confidence that the Atomo device will be part of their catalogue at some point in fy22.
Just to touch on the Atomo RAT test, JK repeatedly stressed that...
Add AT1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.1¢ |
Change
0.001(3.33%) |
Mkt cap ! $19.81M | |||
| Open | High | Low | Value | Volume |
| 3.0¢ | 3.1¢ | 2.9¢ | $4.745K | 159.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 123968 | 3.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.1¢ | 53324 | 2 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
3.1¢ |
Change
0.001 ( 3.33 %) |
||||
| Open | High | Low | Volume | ||
| 3.0¢ | 3.1¢ | 2.9¢ | 32795 | ||
| Last updated 15.59pm 03/05/2024 ? | |||||
| AT1 (ASX) Chart |